Ocular Therapeutix
OCUL
OCUL
73 hedge funds and large institutions have $170M invested in Ocular Therapeutix in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 18 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 76 → 73 (-3)
6.12% less ownership
Funds ownership: 69.91% → 63.79% (-6.1%)
Holders
73
Holding in Top 10
3
Calls
$2.98M
Puts
$1.5M
Top Buyers
| 1 | +$12M | |
| 2 | +$5.73M | |
| 3 | +$4.24M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$3.39M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.17M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$3.76M | |
| 3 | -$928K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$608K |
| 5 |
CI
Cowen Inc
New York
|
-$597K |